Medtech Acquisition Corp.-CWTLSIWPreferred / convertible
13F holders, Q1 2025 (March 31)6holders −2
1new positions
3sold out
$1.18avg. 13F price*
At the end of Q1 2025, 6 institutions reported holding Medtech Acquisition Corp.-CW (TLSIW) in their 13F filings, down 2 from Q4 2024. 1 opened new positions and 3 sold out. The largest holders were Graypoint LLC ($960K), Vestcor Inc ($103K) and B & T Capital Management DBA Alpha Capital Management ($26K).
- Company
- Medtech Acquisition Corp.-CW
- Filed as
- TRISALUS LIFE SCIENCES INC (Q1 2025)
- CUSIP
- 89680M119
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $204 |
| Exits | 3 | $23K |
All 13F filers, Q4 2024 → Q1 2025: 176 shares bought and 32,287 shares sold, net −32,111 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Graypoint LLC | — | No change | 827,590 | $960K |
| Vestcor Inc | — | No change | 70,832 | $103K |
| B & T Capital Management DBA Alpha Capital Management | — | No change | 22,222 | $26K |
| Foster Victor Wealth Advisors, LLC | — | Reduce -31.3% | 12,601 | $15K |
| Wolverine Asset Management LLC | — | Reduce -37.2% | 8,735 | $11K |
| Bank of America Corp. | — | New | 176 | $204 |
"% of holder's portfolio" is TLSIW's weight in each manager's 13F, not the share of Medtech Acquisition Corp.-CW the manager owns.